No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / therapeutic use
-
Dexamethasone / adverse effects
-
Dexamethasone / therapeutic use
-
Doxorubicin / adverse effects
-
Doxorubicin / therapeutic use
-
Drug Resistance, Neoplasm
-
Female
-
Humans
-
Male
-
Middle Aged
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / mortality
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Recurrence
-
Retreatment
-
Sialic Acid Binding Ig-like Lectin 2 / metabolism*
-
Treatment Outcome
-
Vincristine / adverse effects
-
Vincristine / therapeutic use
-
Young Adult
Substances
-
Antibodies, Monoclonal, Humanized
-
Biomarkers
-
CD22 protein, human
-
Sialic Acid Binding Ig-like Lectin 2
-
epratuzumab
-
Vincristine
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide